CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Contributed Capital	Contributed Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Other Comprehensive Loss
Beginning Balance at Jan. 30, 2021	$ 1,086,665		$ 2,496	$ 663,718		$ 1,868,613		$ (1,407,414)	$ (40,748)
Beginning Balance (in shares) at Jan. 30, 2021			166,335
Stock awards	12,553			12,553
Repurchase of common stock from employees	(10,944)							(10,944)
Repurchase of common stock from employees (in shares)			(396)
Reissuance of treasury stock	11,810			(28,515)		11,020		29,305
Reissuance of treasury stock (in shares)			1,732
Net income	95,463					95,463
Other comprehensive income	2,938								2,938
Cash dividends declared and dividend equivalents	(22,922)			678		(23,600)
Ending Balance at May. 01, 2021	$ 1,175,563		$ 2,496	648,434		1,951,496		(1,389,053)	(37,810)
Ending Balance (in shares) at May. 01, 2021	167,671		167,671
Beginning Balance at Jan. 29, 2022	$ 1,423,672	$ (48,856)	$ 2,496	636,355	$ (67,686)	2,203,772	$ 18,830	(1,378,106)	(40,845)
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Beginning Balance (in shares) at Jan. 29, 2022	168,699		168,699
Stock awards	$ 14,154			14,154
Repurchase of common stock from employees	(8,171)							(8,171)
Repurchase of common stock from employees (in shares)			(452)
Reissuance of treasury stock	329			(20,506)		819		20,016
Reissuance of treasury stock (in shares)			1,174
Net income	31,740					31,740
Other comprehensive income	530								530
Cash dividends declared and dividend equivalents	(30,392)			656		(31,048)
Ending Balance at Apr. 30, 2022	$ 1,383,006		$ 2,496	$ 562,973		$ 2,224,113		$ (1,366,261)	$ (40,315)
Ending Balance (in shares) at Apr. 30, 2022	169,421		169,421